WallStreetZenWallStreetZen

NASDAQ: APMD
Apnimed Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for APMD

Based on 3 analysts offering 12 month price targets for Apnimed Inc

Min Forecast
$41.00+41.38%
Avg Forecast
$50.33+73.56%
Max Forecast
$60.00+106.9%

Should I buy or sell APMD stock?

Based on 4 analysts offering ratings for Apnimed Inc.

Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although APMD's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates APMD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their APMD stock forecasts and price targets.

APMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-25
lockedlocked$00.00+00.00%2026-08-25
lockedlocked$00.00+00.00%2026-08-25
lockedlocked$00.00+00.00%2026-08-25

1 of 1

Forecast return on equity

Is APMD forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is APMD forecast to generate an efficient return on assets?

Insufficient data to display

APMD revenue forecast

What is APMD's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$86.6M
Avg 2 year Forecast
$22.4M
Avg 3 year Forecast
$159.9M

APMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APMD$29.00$50.33+73.56%Strong Buy
AKTS$21.88$36.67+67.58%Strong Buy
ANRO$30.27$38.00+25.54%Strong Buy
REPL$13.07$14.75+12.85%Buy
IMTX$8.62$25.00+190.02%Strong Buy
View Top Biotech Stocks

Apnimed Stock Forecast FAQ

Is Apnimed Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: APMD) stock is to Strong Buy APMD stock.

Out of 4 analysts, 2 (50%) are recommending APMD as a Strong Buy, 2 (50%) are recommending APMD as a Buy, 0 (0%) are recommending APMD as a Hold, 0 (0%) are recommending APMD as a Sell, and 0 (0%) are recommending APMD as a Strong Sell.

If you're new to stock investing, here's how to buy Apnimed stock.

What is APMD's revenue growth forecast for 2026-2028?

(NASDAQ: APMD) Apnimed's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 47.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.17%.

Apnimed's revenue in 2026 is N/A.On average, 5 Wall Street analysts forecast APMD's revenue for 2026 to be $3,604,059,800, with the lowest APMD revenue forecast at $3,460,100,566, and the highest APMD revenue forecast at $3,715,547,026. On average, 5 Wall Street analysts forecast APMD's revenue for 2027 to be $930,864,218, with the lowest APMD revenue forecast at $563,014,655, and the highest APMD revenue forecast at $1,409,743,069.

In 2028, APMD is forecast to generate $6,656,761,562 in revenue, with the lowest revenue forecast at $3,897,681,684 and the highest revenue forecast at $9,529,285,313.

What is APMD's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: APMD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -3.94%.

What is APMD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year APMD price target, the average APMD price target is $50.33, with the highest APMD stock price forecast at $60.00 and the lowest APMD stock price forecast at $41.00.

On average, Wall Street analysts predict that Apnimed's share price could reach $50.33 by Aug 25, 2027. The average Apnimed stock price prediction forecasts a potential upside of 73.56% from the current APMD share price of $29.00.

What is APMD's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: APMD) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.